Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apple Hospitality REIT | APLE | Nov 25, 2024 | 16.32 | +1.30 |
Applied Digital | APLD | Nov 25, 2024 | 10.68 | +8.43 |
Applied DNA Sciences | APDN | Nov 25, 2024 | 0.16 | +3.10 |
Applied Industrial Technologies | AIT | Nov 25, 2024 | 278.55 | +0.52 |
Applied Materials | AMAT | Nov 25, 2024 | 174.55 | -0.19 |
Applied Optoelectronics | AAOI | Nov 25, 2024 | 37.91 | -0.21 |
Applied Therapeutics | APLT | Nov 25, 2024 | 9.59 | -0.36 |
Applovin A | APP | Nov 25, 2024 | 319.59 | -4.12 |
AppTech Payments | APCX | Nov 25, 2024 | 0.47 | -1.05 |
Aprea Therapeutics | APRE | Nov 25, 2024 | 2.91 | +1.04 |
AptarGroup | ATR | Nov 25, 2024 | 172.50 | +0.58 |
Aptevo Therapeutics | APVO | Nov 25, 2024 | 0.31 | 0.00 |
Aptiv | APTV | Nov 25, 2024 | 57.13 | +5.06 |
Aptorum Group A | APM | Nov 25, 2024 | 0.70 | -5.41 |
Aptose Biosciences | APTO | Nov 25, 2024 | 0.18 | -3.05 |
APx Acquisition I A | APXI | Nov 25, 2024 | 11.88 | +0.08 |
APx Acquisition I Unit | APXIU | Nov 25, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 25, 2024 | 1.44 | -0.35 |
Aqua Metals | AQMS | Nov 25, 2024 | 2.66 | +23.15 |
AquaBounty Technologies | AQB | Nov 25, 2024 | 1.01 | +7.91 |
Aquaron Acquisition | AQU | Nov 25, 2024 | 11.10 | 0.00 |
Aquaron Acquisition Units | AQUNU | Nov 25, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 25, 2024 | 4.81 | +5.48 |
Aramark | ARMK | Nov 25, 2024 | 41.86 | +2.45 |
ARB IOT Group | ARBB | Nov 25, 2024 | 0.46 | -11.91 |
Arbe Robotics | ARBE | Nov 25, 2024 | 1.93 | +1.58 |
Arbor Realty Trust | ABR | Nov 25, 2024 | 14.76 | +1.23 |
Arbor Realty Trust D Pref | ABR-D | Nov 25, 2024 | 19.27 | +3.05 |
Arbor Realty Trust E Pref | ABR-E | Nov 25, 2024 | 19.25 | +5.19 |
Arbor Realty Trust F Pref | ABR-F | Nov 25, 2024 | 20.84 | +2.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.